ERM proteins, as plasma membrane–cytoskeleton linkers, can directly or indirectly bind with membrane proteins. Several direct membrane binding partners have been identified including CD44, CD43, PSGL-1, ICAM-1–3, and VCAM-1.
38 –41 The crystal structure of the radixin FERM domain bound to the cytoplasmic tail of ICAM2, CD43, or PSGL1 identified a consensus sequence, Arg/Lys/Gln-X-X-Thr-Tyr/Leu-X-X-Ala/Gly (motif-1), that binds in a groove formed by an α-helix and β-strands of subdomain F3.
42 As the first identified ERM direct binding partner, CD44 lacks this sequence homology; however, it binds in the same groove in subdomain F3.
43 In epithelial cells, ERM proteins indirectly interact with membrane proteins through ezrin binding phosphoprotein 50 (EBP50), a protein widely distributed in tissues, especially in those containing polarized epithelia.
44,45 The crystal structure of the moesin FERM domain bound to the EBP50 C-terminal peptide indicated a different binding site on subdomain F3.
42 These results show the existence of versatile ERM binding partners. In the present study, three independent experimental strategies were used to discover and confirm a direct interaction between ezrin and the C terminus of AQP0. The AQP0 C terminus does not have a consensus sequence similar to the aforementioned adhesion molecules or to EBP50; however, the cross-linking data indicate the exact sites of binding on both AQP0 and ezrin (
Table 1). The cross-linking data indicate that the binding site on subdomain F3 is in the region where EBP50 is bound. Different from the other ERM binding partners reported previously, AQP0 is found to interact with both ezrin subdomains F1 and F3, which are separated three-dimensionally. The crystal structure of the radixin FERM domain with P-selectin glycoprotein ligand-1peptide (
2EMT of PDB entry) also indicates the potential interaction of subdomain F1 with F3 binding partners.
46 Additional studies are needed to understand this interaction; however, there are several possible explanations: (1) because the ERM proteins are present in two forms—the active form and the dormant form
22 —different ERM subdomain interactions with AQP0 could arise from different forms of ERM proteins; (2) the ERM proteins exist mainly in the form of dimers or higher order oligomers,
47 and in the latter, the interacting subdomains F1 and F3 could be from different monomers that, when polymerized, bring subdomain F1 of one molecule close to subdomain F3 of another molecule; and (3) more than one ERM protein interacts with a single AQP0 tetramer.